This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Cramer SD, Aplan PD, Durum SK. Therapeutic targeting of IL-7Ralpha signaling pathways in ALL treatment. Blood. 2016;128:473–8.
Ratajczak MZ, Adamiak M. Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking. Leukemia. 2015;29:1452–7.
Tamarit B, Bugault F, Pillet AH, Lavergne V, Bochet P, Garin N, et al. Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells. J Biol Chem. 2013;288:8691–701.
Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest. 2002;109:9–14.
Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31–9.
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, et al. Lipid raft-targeted therapy in multiple myeloma. Oncogene. 2010;29:3748–57.
Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, de Frias M, et al. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts. Clin Cancer Res. 2010;16:2046–54.
Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007;109:711–9.
Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS ONE. 2009;4:e5044.
Gajate C, Mollinedo F. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 2005;280:11641–7.
Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene. 2009;28:3221–34.
Schubbert S, Cardenas A, Chen H, Garcia C, Guo W, Bradner J, et al. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Cancer Res. 2014;74:7048–59.
De Keersmaecker K, Porcu M, Cox L, Girardi T, Vandepoel R, de Beeck JO, et al. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. Haematologica. 2014;99:85–93.
Ivanyi P, Morgan M, Piao W, Ukena SN, Steube K, Ganser A, et al. Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia. Cell Oncol. 2010;32:101–8.
Serafin V, Lissandron V, Buldini B, Bresolin S, Paganin M, Grillo F, et al. Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL. Leukemia. 2017;31:1007–11.
Acknowledgements
We are grateful to Sébastien Causse for his help with the microscopy, Jean-Paul Pais de Barros for the lipidomic study, Julien Guy for help with T-ALL sample characterization and Philip Bastable for editing and critical reading of this manuscript. This study was supported by grants from the association Laurette Fugain (RQ), the Conférence de Coordination Interrégionale du Grand Est—Bourgogne Franche-Comté (CCIRGE-BFC) de la Ligue contre le Cancer (RQ), by the National Research Agency under the program “Investissements d’Avenir” (reference ANR-11-LABX-0021, LipSTIC Labex), by the Conseil Régional de Bourgogne through the plan d’action régional pour l’innovation (PARI) and the European Union through the PO FEDER-FSE Bourgogne 2014/2020 programs. AB was supported by fellowships from the French Ministère de la Recherche et de l’Enseignement Supérieur (MRES) and LS-P by a fellowship from the Conseil Régional de Bourgogne/INSERM. FP and BU have grants from LNCC, INSERM, CEA, and Université Paris Diderot.
Author contributions
AB and RQ conceived the experiments, performed the experiments, and interpreted the data; TA helped with the experiments; LS-P performed the isolation of rafts by flotation on sucrose density gradients; GL performed the proteomic study; J-NB and LD discussed the data; BU and FP provided human T-ALL xenografts and advices in the usage of such models and discussed the data; LD and FP helped with the writing of the manuscript; AB and RQ wrote the manuscript; RQ supervised the research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Buffière, A., Accogli, T., Saint-Paul, L. et al. Saracatinib impairs maintenance of human T-ALL by targeting the LCK tyrosine kinase in cells displaying high level of lipid rafts. Leukemia 32, 2062–2065 (2018). https://doi.org/10.1038/s41375-018-0081-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-018-0081-5
This article is cited by
-
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia
Leukemia (2023)
-
Acute lymphoblastic leukemia-derived extracellular vesicles affect quiescence of hematopoietic stem and progenitor cells
Cell Death & Disease (2022)
-
HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias
Blood Cancer Journal (2021)
-
High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells
Scientific Reports (2020)
-
T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7
Oncogene (2019)